In line with this, in the transgenic TRAMP prostate cancer model – engineered to express prostate-specific antigen (PSA) – Treg-depletion enhances IFNγ production by PSA-specific CD8+ T cells (136). Here, KLK3 is linked to prostate carcinoma.